Interline Therapeutics is a drug discovery company focused on systematically elucidating protein communities to define molecular mechanisms of disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/13/21 | $92,000,000 | Venture |
ARCH Venture Partners Foresite Capital | undisclosed |
